Skip to main content
. 2021 Jan 19;11:640203. doi: 10.3389/fphar.2020.640203

FIGURE 3.

FIGURE 3

Subpopulation of HSPCs in PB are increased in sepsis patients. (A,B) Representative fluorescence-activated plots of CMPs, MEPs, and GMPs in healthy control (A) and sepsis patients (B). (C,D) Representative fluorescence-activated plots of HSCs and MPP cells in healthy control (C) and sepsis patients (D). (E,F) Kinetic analysis of CMPs (E) and HSCs (F). HSPC, hematopoietic stem and progenitor cell; PB, peripheral blood; CMP, common myeloid progenitor; MEP, megakaryocytic–erythroid precursor; GMP, granulocyte–monocyte progenitor; HSC, hematopoietic stem cells; MPP, multipotential progenitor; PBMC, peripheral blood mononuclear cells; C, healthy control; D1, sepsis on day 1; D4, sepsis on day 4; D7, sepsis on day 7. (**p < 0.01).